Managing High-Risk Patients
Hereditary and Acquired Elevated Lifetime Risk of Breast Cancer
Wednesday, April 30
1:00 PM–5:00 PM
1:00 PM–5:00 PM
Course Moderators: Cory A. Donovan, MD; Faina Nakhlis, MD, FACS
Faculty: Cory A. Donovan, MD; Kevin S. Hughes, MD, FACS; Faina Nakhlis, MD, FACS; Jennifer K. Plichta, MD, MS, FACS; Ashley R. Stuckey, MD, FACOG, FACS
Course Description:
This course will review the resources and knowledge necessary to perform pre- and post- test counseling in a busy surgical clinic. Additionally, this course will provide practical management strategies for complex high-risk breast lesions. Participants will review current screening recommendations and breast cancer risk-reducing strategies for high-risk patients with and without germline genetic mutations.
Course Objectives:
At the conclusion of this course, participants should be able to:
- Recognize high-, moderate-, and low-penetrance germline mutations associated with an elevated lifetime breast cancer risk
- Be familiar with breast cancer screening and risk-reduction strategies relevant to those with hereditary predisposition to breast cancer
- Understand proliferative lesions associated with an elevated lifetime breast cancer risk
- Know how to counsel patients with high-risk proliferative lesions with respect to their management on core biopsy and for future breast cancer screening and risk reduction
CME Credit Information:
This live activity has been approved for AMA PRA Category 1 Credit™. Check back for credit designation updates.
Onsite Agenda:
| 1:00 PM | Welcome and Introduction
Cory A. Donovan, MD; Faina Nakhlis, MD, FACS |
| 1:05 PM | Who Should Get Genetic Testing and How?
Kevin S. Hughes, MD, FACS |
| 1:35 PM | Risk Assessment and Post-test Counseling for Patients with Negative and VUS Genetic Results
Jennifer K. Plichta, MD, MS, FACS |
| 2:00 PM | BRCA 1 and 2: Prophylaxis and Prevention in Mutation Carriers
Ashley R. Stuckey, MD, FACOG, FACS |
| 2:30 PM | Break
|
| 2:45 PM | Beyond BRCA: High-risk Screening Strategies and Residual Risk in Patients With Moderate Penetrance Gene Mutations
Cory A. Donovan, MD |
| 3:15 PM | Genetic Testing Panel Round Table
Cory A. Donovan, MD; Jennifer K. Plichta, MD, MS, FACS; Ashley R. Stuckey, MD, FACOG, FACS |
| 3:55 PM | Deep Dive into Lobular Atypia: ALH, Classic LCIS, non-classic LCIS
Faina Nakhlis, MD, FACS |
| 4:25 PM | ADH and Atypical Papillomas
Faina Nakhlis, MD, FACS |
| 4:40 PM | Q&A
|
| 5:00 PM | Adjourn
|
